Hemeo
1 known investors
Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.
AI & Machine LearningDigital HealthHealthtech